Rapastinel acetate
| CAS No. | 491872-39-0 | Cat. No. | BCP24900 |
| Name | Rapastinel acetate | ||
| Synonyms | GLYX-13; GLYX 13; GLYX13; BV-102; BV102; BV 102; TPPT-amide; | ||
| Formula | C20H35N5O8 | M. Wt | 473.52 |
| Description | Rapastinel is a novel antidepressant drug approved as an adjunctive therapy for the treatment of treatment-resistant major depressive disorder. It is a centrally active, intravenously administered (non-orally active) amidated tetrapeptide (Thr-Pro-Pro-Thr-NH2) that acts as a selective, weak partial agonist (mixed antagonist/agonist) of an allosteric site at the glycine site of the NMDA receptor complex (Emax ≈ 25%). | ||
| Related Products | 1435786-04-1（Rapastinel Trifluoroacetate） | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | mGluR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.